stockmarketproxy
/
LHNYSE SEC EDGAR

LABCORP HOLDINGS INC.

Services-Medical Laboratories·BURLINGTON, NC·FY end 12/31·CIK 920148
OverviewFinancialsCompensationGovernanceInsidersFilings

Financials

5-year history · USD
MetricFY 2025FY 2024FY 2023FY 2021FY 2020Trend
Revenue$14.0B$13.0B$12.2B$14.9B$14.0B
Gross Profit$4.0B$3.6B$3.4B$4.4B$5.0B
Operating Income$1.4B$1.1B$725.6M$1.8B$2.4B
Net Income$876.5M$746.0M$418.0M$1.3B$1.6B
Operating CF$1.6B$1.6B$1.3B$2.0B$2.1B
Capex$434.5M$489.9M$453.6M$481.9M$381.7M
Free Cash Flow$1.2B$1.1B$874.1M$1.5B$1.8B
Buybacks$450.0M$250.1M$1.0B$1.1B$100.0M
Dividends——————
Gross Margin28.8%27.9%27.7%29.5%35.4%
Operating Margin9.9%8.4%6.0%11.9%17.5%
Net Margin6.3%5.7%3.4%8.6%11.1%
FCF Margin8.6%8.4%7.2%9.9%12.5%
R&D / Revenue——————
Effective Tax——————
Debt / Equity0.590.660.510.500.58
Buybacks / FCF37.3%22.8%114.4%74.6%5.7%

Peer comparison

Services-Medical Laboratories · 3 peers
CEO Pay Ratio
LH
292:1
DGX
275:1
NTRA
101:1
GH
44:1
CEO total comp
LH
—
DGX
$15M
NTRA
$15M
GH
—
Net Margin
LH
6.3%
DGX
9.0%
NTRA
-9.0%
GH
-42.4%